Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the requirements for the ipledge program for accutane?

See the DrugPatentWatch profile for accutane

What Is iPLEDGE and Who Needs It?

iPLEDGE is a mandatory risk management program for isotretinoin (Accutane and generics), required by the FDA to prevent fetal exposure due to the drug's severe birth defect risks. It applies to all patients, prescribers, pharmacies, and wholesalers. Everyone must register and comply monthly.[1]

Patient Registration and Eligibility Requirements

  • Be able to understand and comply with the program (no exceptions for age or ability).
  • Register online at iPLEDGEreminder.com or by phone.
  • For females of childbearing potential (post-menarche, not surgically sterilized, not postmenopausal): Must use two forms of contraception (e.g., hormonal + barrier) or abstain from sex for the entire treatment and one month after.
  • Complete a patient survey confirming understanding of risks.
  • No new prescriptions without monthly check-ins.[1][2]

Pregnancy Testing Rules for Women

  • Negative pregnancy test (serum or urine, sensitivity ≤25 mIU/mL) required before starting.
  • Two negative tests (one lab serum, one provider-observed urine) in the month before first dose.
  • Monthly negative tests during treatment, with a 7-day "no-touch" window (no drug dispensed 7 days before next test).
  • No refills across state lines without updated negative test in the system.[1]

Monthly Compliance Steps

  1. Patient: Log in monthly, complete survey on contraception/abstinence, review risks.
  2. Prescriber: Enter monthly visit notes confirming compliance (in-person or telehealth where allowed).
  3. Pharmacy: Verify patient's qualification status before dispensing (max 30-day supply).
    All steps must sync in real-time via the iPLEDGE system; delays block prescriptions.[1][2]

Prescriber Responsibilities

  • Register and train on iPLEDGE.
  • Qualify patients monthly (document contraception, risks, psychiatric screening).
  • Cannot prescribe more than a 30-day supply at once.
  • Report adverse events or pregnancies to FDA.[1]

Pharmacy and Dispensing Rules

  • Only dispense if patient is "qualified" in the system that day.
  • No partial fills or transfers without requalification.
  • Wholesalers must register and track distribution.[1]

What Happens If You Miss a Step?

Prescriptions halt until compliance. No grace periods—system locks after 7-day window. Treatment gaps over 1 month require restarting pregnancy tests. Non-compliance ends therapy.[1][2]

Common Issues Patients Face

  • Log-in glitches or forgotten passwords delay access.
  • Travel/state borders complicate refills.
  • Teens/young adults often need parent involvement for registration.
  • Psychiatric history requires extra prescriber documentation.[2]

    Sources
    [1]: FDA iPLEDGE Program
    [2]: iPLEDGE Official Site




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy